clove and Poliomyelitis

clove has been researched along with Poliomyelitis* in 26 studies

Reviews

2 review(s) available for clove and Poliomyelitis

ArticleYear
[Eradication of poliomyelitis and emergence of pathogenic vaccine-derived polioviruses: from Madagascar to Cameroon].
    Medecine sciences : M/S, 2013, Volume: 29, Issue:11

    The oral poliovaccine, a live vaccine made of attenuated poliovirus strains, is the main tool of the vaccination campaigns organised for eradicating poliomyelitis. these campaigns had led to the decline and, thereafter, to the disappearance of wild poliovirus strains of the three serotypes (1-3) in most parts of the world. However, when the poliovaccine coverage becomes too low, vaccine polioviruses can circulate in insufficiently immunized populations and become then pathogenic by mutations and genetic recombination with other enteroviruses of the same species, in particular some coxsackievirus A. These mutated and recombinant vaccine strains have been implicated in several epidemics of paralytic poliomyelitis. Two polio outbreaks associated with these pathogenic circulating vaccine-derived poliovirus (cVDPV) occurred in 2001-2002 and 2005 in the South of Madagascar where vaccine coverage was low. These cVDPV, of serotype 2 or 3, were isolated from paralyzed children and some of their healthy contacts. Other cVDPV were isolated in the same region from healthy children in 2011, indicating that these viruses were circulating again. Vaccination campaigns could stop the outbreaks in 2002 and 2005, and most probably prevent another one in 2011. Therefore, the genetic plasticity of poliovaccine strains that threatens the benefit of vaccination campaigns is the target of an accurate surveillance and an important theme of studies in the virology laboratories of the Institut Pasteur international network.

    Topics: Cameroon; Disease Outbreaks; Enterovirus; Humans; Madagascar; Mass Vaccination; Mutation; Poliomyelitis; Poliovirus; Poliovirus Vaccine, Oral; Recombination, Genetic

2013
Circulating vaccine-derived polioviruses: current state of knowledge.
    Bulletin of the World Health Organization, 2004, Volume: 82, Issue:1

    Within the past 4 years, poliomyelitis outbreaks associated with circulating vaccine-derived polioviruses (cVDPVs) have occurred in Hispaniola (2000-01), the Philippines (2001), and Madagascar (2001-02). Retrospective studies have also detected the circulation of endemic cVDPV in Egypt (1988-93) and the likely localized spread of oral poliovirus vaccine (OPV)-derived virus in Belarus (1965-66). Gaps in OPV coverage and the previous eradication of the corresponding serotype of indigenous wild poliovirus were the critical risk factors for all cVDPV outbreaks. The cVDPV outbreaks were stopped by mass immunization campaigns using OPV. To increase sensitivity for detecting vaccine-derived polioviruses (VDPVs), in 2001 the Global Polio Laboratory Network implemented additional testing requirements for all poliovirus isolates under investigation. This approach quickly led to the recognition of the Philippines and Madagascar cVDPV outbreaks, but of no other current outbreaks. The potential risk of cVDPV emergence has increased dramatically in recent years as wild poliovirus circulation has ceased in most of the world. The risk appears highest for the type 2 OPV strain because of its greater tendency to spread to contacts. The emergence of cVDPVs underscores the critical importance of eliminating the last pockets of wild poliovirus circulation, maintaining universally high levels of polio vaccine coverage, stopping OPV use as soon as it is safely possible to do so, and continuing sensitive poliovirus surveillance into the foreseeable future. Particular attention must be given to areas where the risks for wild poliovirus circulation have been highest, and where the highest rates of polio vaccine coverage must be maintained to suppress cVDPV emergence.

    Topics: Child; Disease Outbreaks; Dominican Republic; Egypt; Haiti; Humans; Immunization Programs; Madagascar; Philippines; Poland; Poliomyelitis; Poliovirus; Poliovirus Vaccine, Oral; Risk Factors; RNA, Viral; Virus Shedding; World Health Organization

2004

Other Studies

24 other study(ies) available for clove and Poliomyelitis

ArticleYear
Strengthened surveillance revealed a rapid disappearance of the poliovirus serotype 2 vaccine strain in Madagascar after its removal from the oral polio vaccine.
    Journal of medical virology, 2022, Volume: 94, Issue:12

    To assess circulation of the Sabin 2 poliovirus vaccine strain in Madagascar after its withdrawal from the oral polio vaccine in April 2016, a reinforced poliovirus surveillance was implemented in three regions of Madagascar from January 2016 to December 2017. Environmental samples and stool specimens from healthy children were screened using the Global Polio Laboratory Network algorithm to detect the presence of polioviruses. Detected polioviruses were molecularly typed and their genomes fully sequenced. Polioviruses were detected during all but 4 months of the study period. All isolates were related to the vaccine strains and no wild poliovirus was detected. The majority of isolates belong to the serotype 3. The last detection of Sabin 2 occurred in July 2016, 3 months after its withdrawal. No vaccine-derived poliovirus of any serotype was observed during the study. Only few poliovirus isolates contained sequences from non-polio origin. The genetic characterization of all the poliovirus isolates did not identify isolates that were highly divergent compared to the vaccine strains. This observation is in favor of a good vaccine coverage that efficiently prevented long-lasting transmission chains between unvaccinated persons. This study underlines that high commitment in the fight against polioviruses can succeed in stopping their circulation even in countries where poor sanitation remains a hurdle.

    Topics: Child; Enterovirus; Humans; Madagascar; Poliomyelitis; Poliovirus; Poliovirus Vaccine, Oral; Serogroup

2022
Enterovirus detection in different regions of Madagascar reveals a higher abundance of enteroviruses of species C in areas where several outbreaks of vaccine-derived polioviruses occurred.
    BMC infectious diseases, 2022, Nov-08, Volume: 22, Issue:1

    Poliomyelitis outbreaks due to pathogenic vaccine-derived polioviruses (VDPVs) are threatening and complicating the global polio eradication initiative. Most of these VDPVs are genetic recombinants with non-polio enteroviruses (NPEVs) of species C. Little is known about factors favoring this genetic macroevolution process. Since 2001, Madagascar has experienced several outbreaks of poliomyelitis due to VDPVs, and most of VDPVs were isolated in the south of the island. The current study explored some of the viral factors that can promote and explain the emergence of recombinant VDPVs in Madagascar.. Between May to August 2011, we collected stools from healthy children living in two southern and two northern regions of Madagascar. Virus isolation was done in RD, HEp-2c, and L20B cell lines, and enteroviruses were detected using a wide-spectrum 5'-untranslated region RT-PCR assay. NPEVs were then sequenced for the VP1 gene used for viral genotyping.. Overall, we collected 1309 stools, of which 351 NPEVs (26.8%) were identified. Sequencing revealed 33 types of viruses belonging to three different species: Enterovirus A (8.5%), Enterovirus B (EV-B, 40.2%), and Enterovirus C (EV-C, 51.3%). EV-C species included coxsackievirus A13, A17, and A20 previously described as putative recombination partners for poliovirus vaccine strains. Interestingly, the isolation rate was higher among stools originating from the South (30.3% vs. 23.6%, p-value = 0.009). EV-C were predominant in southern sites (65.7%) while EV-B predominated in northern sites (54.9%). The factors that explain the relative abundance of EV-C in the South are still unknown.. Whatever its causes, the relative abundance of EV-C in the South of Madagascar may have promoted the infections of children by EV-C, including the PV vaccine strains, and have favored the recombination events between PVs and NPEVs in co-infected children, thus leading to the recurrent emergence of recombinant VDPVs in this region of Madagascar.

    Topics: Child; Disease Outbreaks; Enterovirus; Enterovirus C, Human; Enterovirus Infections; Humans; Madagascar; Phylogeny; Poliomyelitis; Poliovirus; Poliovirus Vaccine, Oral; Poliovirus Vaccines

2022
Why measles deaths are surging - and coronavirus could make it worse.
    Nature, 2020, Volume: 580, Issue:7804

    Topics: Armed Conflicts; Betacoronavirus; Child; Coronavirus Infections; COVID-19; Democratic Republic of the Congo; Developing Countries; Disease Eradication; Disease Outbreaks; Humans; Immunization Programs; Madagascar; Measles; Measles Vaccine; Pandemics; Pneumonia, Viral; Poliomyelitis; SARS-CoV-2; Ukraine; Vitamin A Deficiency; World Health Organization

2020
Hybrid prevalence estimation: Method to improve intervention coverage estimations.
    Proceedings of the National Academy of Sciences of the United States of America, 2018, 12-18, Volume: 115, Issue:51

    Delivering excellent health services requires accurate health information systems (HIS) data. Poor-quality data can lead to poor judgments and outcomes. Unlike probability surveys, which are representative of the population and carry accuracy estimates, HIS do not, but in many countries the HIS is the primary source of data used for administrative estimates. However, HIS are not structured to detect gaps in service coverage and leave communities exposed to unnecessary health risks. Here we propose a method to improve informatics by combining HIS and probability survey data to construct a hybrid estimator. This technique provides a more accurate estimator than either data source alone and facilitates informed decision-making. We use data from vitamin A and polio vaccination campaigns in children from Madagascar and Benin to demonstrate the effect. The hybrid estimator is a weighted average of two measurements and produces SEs and 95% confidence intervals (CIs) for the hybrid and HIS estimators. The estimates of coverage proportions using the combined data and the survey estimates differ by no more than 3%, while decreasing the SE by 1-6%; the administrative estimates from the HIS and combined data estimates are very different, with 3-25 times larger CI, questioning the value of administrative estimates. Estimators of unknown accuracy may lead to poorly formulated policies and wasted resources. The hybrid estimator technique can be applied to disease prevention services for which population coverages are measured. This methodology creates more accurate estimators, alongside measured HIS errors, to improve tracking the public's health.

    Topics: Child; Child Health Services; Child, Preschool; Computer Simulation; Delivery of Health Care; Health Information Systems; Health Services Research; Humans; Immunization Programs; Infant; Madagascar; Poliomyelitis; Prevalence; Program Evaluation; Surveys and Questionnaires; Vaccination

2018
Notes from the Field: Circulating Vaccine-Derived Poliovirus Outbreaks - Five Countries, 2014-2015.
    MMWR. Morbidity and mortality weekly report, 2016, Feb-12, Volume: 65, Issue:5

    In 2015, wild poliovirus (WPV) transmission was identified in only Afghanistan and Pakistan (1). The widespread use of live, attenuated oral poliovirus vaccine (OPV) has been key in polio eradication efforts. However, OPV use, particularly in areas with low vaccination coverage, is associated with the low risk for emergence of vaccine-derived polioviruses (VDPV), which can cause paralysis (2). VDPVs vary genetically from vaccine viruses and can cause outbreaks in areas with low vaccination coverage. Circulating VDPVs (cVDPVs) are VDPVs in confirmed outbreaks. Single VDPVs for which the origin cannot be determined are classified as ambiguous (aVDPVs), which can also cause paralysis. Among the three types of WPV, type 2 has been declared to be eradicated. More than 90% of cVDPV cases have been caused by type 2 cVDPVs (cVDPV2). Therefore, in April 2016, all OPV-using countries of the world are discontinuing use of type 2 Sabin vaccine by simultaneously switching from trivalent OPV (types 1, 2, and 3) to bivalent OPV (types 1 and 3) for routine and supplementary immunization. The World Health Organization recently broadened the definition of cVDPVs to include any VDPV with genetic evidence of prolonged transmission (i.e., >1.5 years) and indicated that any single VDPV2 event (a case of paralysis caused by a VDPV or isolation of a VDPV from an environmental specimen) should elicit a detailed outbreak investigation and local immunization response. A confirmed cVDPV2 detection should elicit a full poliovirus outbreak response that includes multiple supplemental immunization activities (SIAs); an aVDPV designation should be made only after investigation and response (3). Since 2005, there have been 1-8 cVDPV outbreaks and 3-12 aVDPV events per year. There are currently five active cVDPV outbreaks in Guinea, Laos, Madagascar, Myanmar, and Ukraine, and four other active VDPV events.

    Topics: Disease Outbreaks; Guinea; Humans; Laos; Madagascar; Myanmar; Poliomyelitis; Poliovirus Vaccine, Oral; Ukraine

2016
Circulating vaccine-derived poliovirus outbreaks in 5 countries, 2014-2015.
    Releve epidemiologique hebdomadaire, 2016, Feb-12, Volume: 91, Issue:6

    Topics: Child; Disease Outbreaks; Guinea; Humans; Immunization; Laos; Madagascar; Myanmar; Poliomyelitis; Poliovirus; Poliovirus Vaccine, Oral; Ukraine

2016
Madagascar's health challenges.
    Lancet (London, England), 2015, Aug-22, Volume: 386, Issue:9995

    Topics: Budgets; Female; Health Expenditures; Health Services; Health Services Accessibility; HIV Infections; Humans; Madagascar; Malaria; Male; Plague; Poliomyelitis; Politics

2015
Reemergence of recombinant vaccine-derived polioviruses in healthy children, Madagascar.
    Emerging infectious diseases, 2013, Volume: 19, Issue:6

    Topics: Capsid Proteins; Child, Preschool; Disease Outbreaks; Humans; Infant; Madagascar; Phylogeny; Poliomyelitis; Poliovirus; Poliovirus Vaccine, Oral

2013
Common and diverse features of cocirculating type 2 and 3 recombinant vaccine-derived polioviruses isolated from patients with poliomyelitis and healthy children.
    The Journal of infectious diseases, 2012, May-01, Volume: 205, Issue:9

    Five cases of poliomyelitis due to type 2 or 3 recombinant vaccine-derived polioviruses (VDPVs) were reported in the Toliara province of Madagascar in 2005.. We sequenced the genome of the VDPVs isolated from the patients and from 12 healthy children and characterized phenotypic aspects, including pathogenicity, in mice transgenic for the poliovirus receptor.. We identified 6 highly complex mosaic recombinant lineages composed of sequences derived from different vaccine polioviruses and other species C human enteroviruses (HEV-Cs). Most had some recombinant genome features in common and contained nucleotide sequences closely related to certain cocirculating coxsackie A virus isolates. However, they differed in terms of their recombinant characteristics or nucleotide substitutions and phenotypic features. All VDPVs were neurovirulent in mice.. This study confirms the genetic relationship between type 2 and 3 VDPVs, indicating that both types can be involved in a single outbreak of disease. Our results highlight the various ways in which a vaccine-derived poliovirus may become pathogenic in complex viral ecosystems, through frequent recombination events and mutations. Intertypic recombination between cocirculating HEV-Cs (including polioviruses) appears to be a common mechanism of genetic plasticity underlying transverse genetic variability.

    Topics: Animals; Child; Disease Outbreaks; Enterovirus C, Human; Female; Genome, Viral; Humans; Madagascar; Male; Mice; Phenotype; Phylogeny; Poliomyelitis; Poliovirus; Poliovirus Vaccines; Protein Conformation; Recombination, Genetic; RNA, Viral; Sequence Analysis, DNA; Vaccines, Synthetic

2012
Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses.
    PLoS pathogens, 2009, Volume: 5, Issue:5

    Ten outbreaks of poliomyelitis caused by pathogenic circulating vaccine-derived polioviruses (cVDPVs) have recently been reported in different regions of the world. Two of these outbreaks occurred in Madagascar. Most cVDPVs were recombinants of mutated poliovaccine strains and other unidentified enteroviruses of species C. We previously reported that a type 2 cVDPV isolated during an outbreak in Madagascar was co-circulating with coxsackieviruses A17 (CA17) and that sequences in the 3' half of the cVDPV and CA17 genomes were related. The goal of this study was to investigate whether these CA17 isolates can act as recombination partners of poliovirus and subsequently to evaluate the major effects of recombination events on the phenotype of the recombinants. We first cloned the infectious cDNA of a Madagascar CA17 isolate. We then generated recombinant constructs combining the genetic material of this CA17 isolate with that of the type 2 vaccine strain and that of the type 2 cVDPV. Our results showed that poliovirus/CA17 recombinants are viable. The recombinant in which the 3' half of the vaccine strain genome had been replaced by that of the CA17 genome yielded larger plaques and was less temperature sensitive than its parental strains. The virus in which the 3' portion of the cVDPV genome was replaced by the 3' half of the CA17 genome was almost as neurovirulent as the cVDPV in transgenic mice expressing the poliovirus cellular receptor gene. The co-circulation in children and genetic recombination of viruses, differing in their pathogenicity for humans and in certain other biological properties such as receptor usage, can lead to the generation of pathogenic recombinants, thus constituting an interesting model of viral evolution and emergence.

    Topics: Animals; Cell Line, Tumor; Cloning, Molecular; Disease Models, Animal; Enterovirus; Female; Genome, Viral; Humans; Madagascar; Male; Mice; Mice, Transgenic; Phylogeny; Poliomyelitis; Poliovirus; Poliovirus Vaccines; Recombination, Genetic; Sequence Alignment; Sequence Analysis, DNA; Temperature; Vaccines, Attenuated; Viral Plaque Assay; Virulence; Virus Replication

2009
Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar.
    The Journal of infectious diseases, 2008, May-15, Volume: 197, Issue:10

    After the 2001-2002 poliomyelitis outbreak due to recombinant vaccine-derived polioviruses (VDPVs) in the Toliara province of Madagascar, another outbreak reoccurred in the same province in 2005.. We conducted epidemiological and virological investigations for each polio case patient and for their contacts.. From May to August 2005, a total of 5 cases of acute flaccid paralysis were reported among unvaccinated or partially vaccinated children 2-3 years old. Type-3 or type-2 VDPV was isolated from case patients and from healthy contacts. These strains were classified into 4 recombinant lineages that showed complex mosaic genomic structures originating from different vaccine strain serotypes and probably from human enterovirus C (HEV-C) species. Genetic relatedness could be observed among these 4 lineages. Vaccination coverage of the population was very low (<50%).. The broad distribution of VDPVs in the province and their close genetic relationship indicate intense and rapid cocirculation and coevolution of the vaccine strains and of their related HEV-C strains. The occurrence of an outbreak due to VDPV 3 years after a previous outbreak indicates that a short period with low vaccination coverage is enough to create favorable conditions for the emergence of VDPV in this setting.

    Topics: Child, Preschool; Disease Outbreaks; Enterovirus C, Human; Humans; Madagascar; Male; Phylogeny; Poliomyelitis; Poliovirus; Poliovirus Vaccines; Recombination, Genetic; RNA, Viral; Sequence Analysis, DNA; Vaccines, Synthetic

2008
[Poliovirus vaccination and emergence of recombinant vaccine derived from vaccinal strains in Madagascar].
    Medecine et maladies infectieuses, 2004, Volume: 34 Suppl 1

    Topics: Child; Humans; Infant; Madagascar; Male; Poliomyelitis; Poliovirus; Poliovirus Vaccines; Recombination, Genetic

2004
Recombinant vaccine-derived poliovirus in Madagascar.
    Emerging infectious diseases, 2003, Volume: 9, Issue:7

    Topics: Child; Enterovirus; Female; Humans; Infant; Madagascar; Male; Poliomyelitis; Poliovirus; Poliovirus Vaccines; Polymorphism, Restriction Fragment Length; Recombination, Genetic; Sequence Analysis, DNA; Vaccination

2003
[Genetic variability of Poliovirus: typing of strains isolated in Madagascar by restriction fragment length polymorphism (RFLP) assay].
    Archives de l'Institut Pasteur de Madagascar, 2003, Volume: 69, Issue:1-2

    The differentiation of the vaccine or wild origin of Poliovirus at the laboratory is an important step towards the process of the poliomyelitis eradication. We report herein the results obtained from Poliovirus types 3 and 2, isolated in Madagascar in 1997 and 2002 from healthy children and cases of acute flaccid paralysis, respectively. The technique used is based on the amplification of genome (RT-PCR), followed by Restriction Fragment Length Polymorphism assay (RFLP), performed in 3 different regions of the genome. In the capsid region (VP3-VP1 and VP1-2A), RFLP analysis allowed us to differentiate without ambiguity the wild or vaccine origin of the Poliovirus type 3, and to identify Vaccine-Derived Poliovirus (VDPV) type 2. In the noncapsid region, including the RNA polymerase and 3' non coding region (3Dpol-3' NTR), the VDPV were found to be recombinant with other Enteroviruses. These results confirm that RFLP assay is a reliable tool for intratypic differentiation and to study the genetic drift and recombination of Poliovirus.

    Topics: Capsid Proteins; Case-Control Studies; Child; DNA-Directed RNA Polymerases; DNA, Viral; Genetic Drift; Genetic Variation; Genome, Viral; Humans; Madagascar; Poliomyelitis; Poliovirus; Poliovirus Vaccine, Oral; Polymorphism, Restriction Fragment Length; Recombination, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Untranslated; RNA, Viral

2003
Paralytic poliomyelitis in Madagascar, 2002.
    Releve epidemiologique hebdomadaire, 2002, Jul-19, Volume: 77, Issue:29

    Topics: Child; Disease Outbreaks; Humans; Madagascar; Poliomyelitis; Population Surveillance

2002
Stamps in paediatrics: Poliomyelitis.
    Archives of disease in childhood, 2001, Volume: 84, Issue:4

    Topics: Eswatini; History, 20th Century; Humans; Madagascar; Philately; Poliomyelitis

2001
Mass vaccination campaigns to eradicate poliomyelitis in Madagascar: oral poliovirus vaccine increased immunity of children who missed routine programme.
    Tropical medicine & international health : TM & IH, 2001, Volume: 6, Issue:12

    To assess the impact of mass vaccination campaigns using oral poliovirus vaccine (OPV) in Madagascar, serum neutralizing antibodies and geometrical mean titres (GMTs) to poliovirus were measured among 472 children aged up to 59 months, before and after the mass campaign, regardless of their previous history of routine vaccination. In this study, overall coverage with three routine and two mass campaign OPV doses was 69.9 and 93.4%, respectively. Seroprevalences to all poliovirus types were significantly higher after the mass campaign among the children who were not vaccinated through routine programme: 67.5% vs. 90.2% (P < 0.001) for type 1; 66.7% vs. 95.1% (P < 0.001) for type 2; and 55.3% vs. 82.9% (P < 0.001) for type 3. Geometrical mean titres to all poliovirus types also significantly increased after the mass campaign among the same study group: 34.5 vs. 238.9 (P < 0.001) for type 1; 35.1 vs. 402.6 (P < 0.001) for type 2; and 13.3 vs. 92.6 (P < 0.001) for type 3. Post-mass campaign seroprevalences and GMTs for poliovirus, especially types 1 and 3, among children who received up to two routine and two mass campaign OPV doses were significantly higher than pre-mass campaign seroprevalences among children who received three routine OPV doses. Reasons for lack of adherence to the vaccination programme and the mass campaign are discussed. The findings strongly support the WHO strategy of conducting mass campaign in all endemic countries. However, as the mass campaign strategy now has been discontinued, it is crucial to increase the routine coverage and to improve acute flaccid paralysis surveillance in order to fulfil the goal of poliomyelitis eradication.

    Topics: Antibodies, Viral; Child; Child, Preschool; Female; Humans; Immunization Programs; Immunization Schedule; Infant; Infant, Newborn; Madagascar; Male; Neutralization Tests; Poliomyelitis; Poliovirus; Poliovirus Vaccine, Oral; Vaccination

2001
[Acute flaccid paralysis after drug injection: a case report in the pediatric service of the Befelatanana Hospital Center in Antananarivo].
    Archives de l'Institut Pasteur de Madagascar, 2000, Volume: 66, Issue:1-2

    In the framework of the poliomyelitis program eradication, the World Health Organization suggests two markers to survey the circulation of the poliovirus: notification of all cases of acute flask paralysis (AFP) and etiological research of these AFP from two stool samples. The authors reported the case of a AFP, occurring after a polio vaccination in a 5-year-old boy who had later an acute rhinopharyngitis treated by antibiotics and quinine intramuscular injections. A left lower limb AFP justified his hospitalisation. The isolation of a Sabin type 3 poliovirus was a pitfall because clinical and complementary investigations demonstrate a peripheral neuromuscular paralysis. This demonstrative case shows the need for health staff to be trained to perform correctly an usual act like intramuscular drug injections.

    Topics: Acute Disease; Anti-Bacterial Agents; Child, Preschool; Diagnosis, Differential; Disease Notification; Feces; Humans; Injections, Intramuscular; Madagascar; Male; Nasopharyngitis; Paralysis; Poliomyelitis; Poliovirus; Poliovirus Vaccine, Oral; Quinine; Sciatic Nerve

2000
[Circulation of the poliovirus in endemic zones with children vaccinated by the oral polio vaccine].
    Bulletin de la Societe de pathologie exotique (1990), 2000, Volume: 93, Issue:3

    Strategies aiming to eradicate the poliovirus and poliomyelitis seek primarily to eliminate wild strains associated with the disease, by means of world wide vaccination campaigns using the oral attenuated vaccine (OPV). OPV contains attenuated viral strains which retain their replicating capacity in the digestive tract and thus induce the development of an antiviral local intestinal immunity and limit the circulation of the virus. In such a context, poliomyelitis surveillance laboratories should study above all cases of acute flaccid paralysis (AFP), highlighting the circulation of wild strains, identifying regional reservoirs and guiding vaccination strategies. Alongside circulation, there appear to be important genetic and phenotypic shifts in vaccinating strains, since the OPV is capable of preserving a reservoir of pathogenic stains and thereby impairing vaccination efficacy and the eradication of the virus. Furthermore, non-polio enteroviruses should be considered as a source of emerging pathogenic strains. These questions are being studied by the Pasteur Institute with the objective of determining the effects of OPV campaigns on the circulation of the poliovirus. We have studied the poliovirus vaccine and the circulation of wild strains in urban and peripheral urban areas in African countries known to be endemic for poliomyelitis (Central African Republic, Madagascar, Côte d'Ivoire). The study population consisted of children who had already been vaccinated and new-borns in the course of vaccination. We also evaluated the diffusion of the vaccine strains in their immediate environment. Genetic interchanges were taken into account. For children who received the 3-4 OPV doses, asymptomatic virus excretion was insignificant (0.4-2.4%). The rate of virus excretion in the surrounding environment of children in the course of being vaccinated was relatively low (1.76-5.3%). Our study also detected variant and recombinant strains.

    Topics: Central African Republic; Child, Preschool; Cote d'Ivoire; Endemic Diseases; Female; Humans; Infant; Madagascar; Male; Poliomyelitis; Poliovirus; Poliovirus Vaccine, Oral; Polymorphism, Restriction Fragment Length; Vaccination

2000
Wild poliovirus circulation among healthy children immunized with oral polio vaccine in Antananarivo, Madagascar.
    Tropical medicine & international health : TM & IH, 1999, Volume: 4, Issue:1

    From July 1995 to December 1996, 3185 stool specimens from healthy children aged 6-59 months attending 6 dispensaries in the Antananarivo area were examined for poliovirus. The children had been routinely immunized according to the Expanded Programme on Immunization (EPI) schedule and received the last dose of oral polio vaccine (OPV) more than 1 month before stool collection. 99.4% of the children were immunized with at least 3 doses of OPV. HEp-2 cell culture revealed virus infections in 192 stools (6.0%), including 9 poliovirus (0.3%) and 183 nonpolio enterovirus isolates (5.7%). Infections occurred throughout the year, but incidence was higher during the hot and rainy season (P=0.01). Using a neutralization test with monoclonal antibodies and PCR-RFLP in two genomic regions coding for the VP1 capsid and RNA polymerase, 4 wild polioviruses (3 type 1 and 1 type 3) and 5 vaccine-related polioviruses (2 Sabin 1-like variants, 1 Sabin 2-like and 2 Sabin 3-like) strains were identified. The wild polioviruses were isolated at the beginning and the end of the dry season. Similar RFLP patterns were observed for the 3 wild type 1 polioviruses. Comparison of partial genomic sequences in the VP1/2 A region of 1 of the wild type 1 isolates with 2 wild type strains isolated in Antananarivo in 1992 and 1993 showed a divergence of at least 10% between the strains, suggesting at least two different pathways of transmission during this period. Our findings demonstrate that immunization with 3 doses of OPV did not prevent intestinal carriage of wild poliovirus strains, and that there is a risk of wild poliovirus transmission to susceptible children in the area. Multiple strategies are required to improve immunization coverage in Madagascar.

    Topics: Age Distribution; Base Sequence; Child, Preschool; DNA, Viral; Feces; Female; Genetic Variation; Humans; Madagascar; Male; Molecular Sequence Data; Poliomyelitis; Poliovirus; Poliovirus Vaccine, Oral; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Risk Factors; Seasons; Serotyping

1999
[Poliomyelitis in Madagascar (1988-1996): current situation in the World Health eradication program by the year 2000].
    Archives de l'Institut Pasteur de Madagascar, 1996, Volume: 63, Issue:1-2

    The number of acute flaccid paralysis (AFP) cases reported to World Health Organization (WHO) decreased from 1988 (48 cases) to 1996 (8 cases), but the real endemic situation of poliomyelitis is unknown. Cases are under or misreported. Very often, notifications are delayed; virological investigations of the etiology could not be performed as well as the environment studies and the immunization ripostes. In 1996, only one AFP case was confirmed by isolation of wild poliovirus. The immunization coverage in children under one by OPV (3 doses) was 73.0% in 1996 from the statistics of the Public Health Services but only 54.7% from randomized studies. The eradication of poliomyelitis by the year 2000 has engaged Madagascar in the disease prevention by improving the immunization coverage within the Expanded Immunization Programme in association with the Organization of National Immunization Days in October and November 1997. Likewise, the Virological Unit of the Pasteur Institute was recognized as the National WHO Reference Centre for Polio.

    Topics: Adolescent; Age Distribution; Child; Child, Preschool; Disease Notification; Endemic Diseases; Humans; Infant; Madagascar; Poliomyelitis; Population Surveillance; Regional Medical Programs; Vaccination; World Health Organization

1996
[Poliomyelitis situation in Madagascar in 1993. Several considerations about the role of the laboratory in the eradication strategy].
    Archives de l'Institut Pasteur de Madagascar, 1993, Volume: 60, Issue:1-2

    After he has explained the worldwide strategy of poliovirus eradication, the author describes the Madagascar situation by reporting the rate of vaccinal coverage and the current surveillance system. He underlines the importance of laboratory in the poliomyelitis diagnosis, the isolated strain serotyping, the determination of strain characteristics: wild or Sabin-like, and their variability. From 1985 to the first five months of 1993, 65 poliovirus strains had been isolated, the most frequent of them is serotype 1. The realization of a map of neutralization epitope on a few type 1 poliovirus strains showed a major part of wild strains; the same case is valid for two other serotypes. The RFLP analysis of 6 type 1 poliovirus strains allowed to record their identity.

    Topics: Diagnosis, Differential; Genotype; Humans; Incidence; Laboratories; Madagascar; Organizational Objectives; Poliomyelitis; Poliovirus; Poliovirus Vaccine, Oral; Polymorphism, Restriction Fragment Length; Population Surveillance; Serotyping; Vaccination

1993
[Poliomyelitis syndromes in Madagascar seen at the Laboratory of Virology 1978-1979. Epidemiologic and prophylactic data].
    Archives de l'Institut Pasteur de Madagascar, 1981, Volume: 48, Issue:1

    Topics: Age Factors; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Madagascar; Male; Poliomyelitis; Poliovirus Vaccine, Inactivated; Seasons

1981
[The re-education center for the poliomyelitis cripples of Madagascar].
    Techniques hospitalieres, medico-sociales et sanitaires, 1955, Volume: 11, Issue:123

    Topics: Asian People; Black People; Humans; Madagascar; Physical Therapy Modalities; Poliomyelitis

1955